HighLife
Trans-septal Mitral Valve Replacement
France
84 employees
Series C
Total: $48.30M
Health Care, Medical Devices
General Information
Get notified when HighLife moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track HighLife
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
France Market
Health Care
About HighLife
Taxonomy: Transcatheter Mitral Valve Replacement, Minimally Invasive Technology, Prosthetic Mitral Valve, Clinical Evaluation, Heart Valve Innovation, Medical Device, Cardiovascular Treatment, Beating Heart Surgery, Anatomical Preservation, Medical Technology, Innovation in Cardiology, Transcatheter Surgery, Mitral Valve Regurgitation, Ease of Use, Patient Safety
Services & Products
Target Customers
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series C | •••••• | 1 |
|
11 Dec 2020 |
| Series B | •••••• | 5 |
|
17 Jan 2019 |
| Series A | •••••• | 3 |
|
30 Oct 2017 |
HighLife Alternatives & Competitors
View All Alternatives
HVR Cardio is a medical device company focused on developing first-generation transcatheter mitral v...
Fixing Hearts and Saving Lives
Advanced transcatheter therapy for resilient heart health and optimal blood flow
FAQ About HighLife
Don't just browse. Track.
Signal Tracker monitors HighLife and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.